Media Inquiries

If you are interested in interviewing a CCR scientist, OR you are a scientist who has been contacted by a member of the media, please contact the NCI Press Office at ncipressofficers@mail.nih.gov or by phone at 240.760.6600.

Clinical Trials

Canva image of female doctor with male patient

Clinical trial researching combination drug therapy for multiple myeloma

A clinical trial led by Elizabeth M. Hill, M.D., Assistant Research Physician in the Lymphoid Malignancies Branch, is researching hematopoietic stem cell transplants and therapy for acute myeloid leukemia.

Clinical trial researching therapy for bile duct cancer

A clinical trial led by Jonathan Hernandez, M.D., Investigator in the Surgical Oncology Program, is researching a combination of immunotherapy and chemotherapy for liver-only cholangiocarcinoma.

The middle portion of the gastrointestinal tract is a common location for cancerous neuroendocrine tumors to form.

Clinical trial evaluates drug combination for inoperable neuroendocrine tumors

Neuroendocrine tumors occur in cells of the endocrine and nervous systems. A combined phase I/II clinical trial at the NIH Clinical Center evaluates the effectiveness of a combination of two agents that may work in complementary ways to target inoperable or metastatic neuroendocrine tumors.

image of female physician using a stethoscope on a young female patient

Clinical trial researching T-cell therapy for sarcoma

John W. Glod, M.D., Ph.D., Associate Research Physician in the Pediatric Oncology Branch, is leading NCI’s participation in a clinical trial researching T-cell therapy for sarcomas.

Clinical trial researching therapy for tumors that have spread to the lining of the abdomen

A clinical trial led by Andrew M. Blakely, M.D., Assistant Research Physician in the Surgical Oncology Program, is researching a combination drug therapy for peritoneal carcinomatosis, a condition in which tumors have spread along the lining of the abdomen from the appendix, colon, ovary or mesothelioma.

Clinical trial researches drug therapy for bone marrow neoplasms

A clinical trial led by Steven Z. Pavletic, M.D., Senior Clinician in the Immune Deficiency Cellular Therapy Program, is researching a therapy for myelodysplastic syndromes (MDS), a group of bone marrow neoplasms.

Clinical trial researching therapy for prostate cancer

A clinical trial led by Ravi A. Madan, M.D., Senior Clinician in the Genitourinary Malignancies Branch, is researching a combination drug therapy for prostate cancer.

Stock image of female African-American doctor with female patient in office setting.

Clinical trial researching therapy for cancers of the reproductive system

A clinical trial led by Jung-Min Lee, M.D., Lasker Clinical Research Scholar in the Women’s Malignancies Branch, is researching a combination drug therapy for cancers of the ovaries, fallopian tubes or peritoneum.

Clinical trial researches immunotherapy for recurrent thymoma and thymic carcinoma

A clinical trial led by Arun Rajan, M.D., Senior Clinician in the Thoracic and GI Malignancies Branch, is researching treatments, including immunotherapy, for recurrent thymoma and thymic carcinoma.

Clinical trial researching immunotherapy for B-cell lymphoma

A clinical trial led by Mark Roschewski, M.D., Senior Clinician in the Lymphoid Malignancies Branch, is researching immunotherapy for indolent B-cell lymphoma, a cancer of white blood cells that frequently relapses.

Breadcrumb

Clinical Trials